CoChat

Mutation of a kinase allosteric node uncouples dynamics linked to phosphotransfer

Open access
Ahuja, Lalima G., Kornev, Alexandr P., McClendon, Christopher L., Veglia, Gianluigi, Taylor, Susan S. · 2017 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; none of the 28 sources its claims cite is checked for support yet.

Abstract

Significance: Our Girvan–Newman-based community network analysis provides a strategy to explore the effects of protein kinase mutations on the dynamic properties of the kinase core and the allosteric network underlying the catalytic cycle. With this approach, which allows us to identify subtle shifts in dynamics and in particular side-chain rotamer preferences, we can explain the underlying mechanism for loss of function in many different scenarios. Our method is especially relevant for disease-causing mutations that lie far from the active site but show no obvious structural perturbations based on X-ray crystallography.

Overview

CoChat Summary

TL;DR

The paper combines biochemical kinetics and Girvan–Newman community analysis of molecular dynamics to show that the distal PKA mutation Y204A uncouples dynamic allosteric networks required for nucleotide–peptide synergy, while leaving ATP hydrolysis largely intact. It explains how a mutation far from the active site can impair phosphotransfer without obvious static structural changes.

Key findings

  • Y204A is severely deficient in phosphotransfer to Kemptide: ∼70-fold decrease in kcat/Km, with turnover of only 0.33 s−1, while ATP Km is not significantly altered (26.8 ± 2.5 µM for Y204A vs. 34.1 ± 0.2 µM for wtPKA). It lacks the wild-type burst phase, shifting the rate-limiting step from ADP release (stage V) to stage II.
  • Y204A retains ATP hydrolysis: ATPase kcat is 62.2 ± 3.1 min−1 vs. 83.7 ± 1.2 min−1 for wtPKA; T1/2 is 0.91 min vs. 0.61 min; ATPase Km for ATP is 218.1 ± 24.5 µM vs. 26.9 ± 1.1 µM. It binds nucleotides with enhanced affinity (AMP-PNP KD 21.4 ± 1.5 µM).
  • Nucleotide–pseudosubstrate synergy is abolished: wtPKA AMP-PNP KD is 41.1 ± 3.0 µM and is enhanced ∼1,000-fold to 66.5 ± 0.3 nM by FAM-IP20; Y204A AMP-PNP KD with FAM-IP20 is 44.7 ± 0.3 µM, twofold worse than without FAM-IP20, and FAM-IP20 KD with saturating AMP-PNP is 3.8 µM for Y204A vs. 1.9 nM for wtPKA.
  • Community maps show Y204A splits into 10 communities vs. 8 in wild type; ComF splits into ComF/ComF1 (87 residues in wtPKA vs. 125 in Y204A), ComH is replaced by ComG, ComC splits, and ComD/ComD1 reorganize. Altered side-chain rotamers occur for K72/E91, D184, N171, and others, despite Y204 being 17.7 Å from the γ-phosphate.

Methods

  • Biochemical assays used recombinant murine PKA catalytic subunit and Y204A, coexpressed with GST-PDK1 for Thr197 phosphorylation. Measurements included steady-state and pre-steady-state phosphotransfer with Kemptide and 32P-ATP, intrinsic tryptophan fluorescence for nucleotide binding, Malachite Green ATPase assays, differential scanning fluorimetry, and fluorescence polarization with FAM-IP20.
  • Molecular dynamics simulations started from PDB 3FJQ, with Y204 mutated in silico to alanine, in the protein:ATP:1Mg2+ complex form. Simulations used AMBER14 and Anton for 5.7 µs (wtPKA) and 5.1 µs (Y204A), followed by mutual-information/MutInf analysis and Girvan–Newman community detection.

Limitations

  • Stated in the paper: the community maps are for the ATP-1Mg2+–bound structure, so it cannot be ruled out that nucleotide binding itself stabilizes communities in Y204A; the Y204A crystal had IP20 bound, masking γ-phosphate dynamics; and experimental validation of conformational entropy by NMR is complex and only partly understood.
  • Evident from the text: the simulations sample only one nucleotide/metal state and one mutant, and the study does not directly measure conformational entropy experimentally; extension to uncharacterized disease mutations is proposed as future work.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1620667114

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 68 Own results and interpretations

49 more claims

Create a free account to see all 88 claims and to verify the 28 references still open.

See all claims — free account
  • It may state two separate claims as one. 18
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. 10.1021/bi952144 · doi:10.1021/bi952144

Cited by

See all 62

Metadata

Authors
Ahuja, L. G., Kornev, A. P., McClendon, C. L., Veglia, G., & Taylor, S. S.
Affiliations
  • University of California San Diego (US)
  • Pfizer (United States) (US)
  • University of Minnesota (US)
Venue
Proceedings of the National Academy of Sciences
Published
2017-01-23
Volume
114
Issue
6
Pages
E931-E940
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2582881706
Cited by
62
References
41
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 14 · 2022: 7 · 2021: 8 · 2020: 2 · 2019: 8 · 2018: 8 · 2017: 3
FWCI
1.98
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
HHS | NIH | National Institute of General Medical Sciences (GM100310, GM034921)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
protein kinases, allosteric regulation, protein kinase A, kinase domain, participatory mapping, Girvan-Newman algorithm, protein dynamics, conformational entropy, phosphotransfer, catalytic cycle, kinase kinetics
MeSH terms
Algorithms, Allosteric Regulation, Allosteric Site, Animals, Kinetics, Models, Molecular, Mutation, Phosphorylation, Protein Conformation, Cyclic AMP-Dependent Protein Kinases, Crystallography, X-Ray, Entropy, Catalytic Domain, Mice, Biocatalysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.